TAMMY SLOTT: Open Payments
NPI 1114265204 · ELKHART, IN. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$721 in 33 payments from 11 companies in 2025. Trend: 2023 $526 · 2024 $821 · 2025 $721
Food & beverage: $686Education: $35
| Company | Payments | Amount |
|---|---|---|
| GlaxoSmithKline, LLC. | 13 | $226 |
| AstraZeneca Pharmaceuticals LP | 6 | $162 |
| Insmed, Inc. | 2 | $57 |
| Viatris Specialty LLC | 2 | $51 |
| Amgen Inc. | 2 | $45 |
| Ethicon Inc. | 1 | $43 |
| Genentech USA, Inc. | 2 | $41 |
| Takeda Pharmaceuticals U.S.A., Inc. | 2 | $34 |
| Regeneron Healthcare Solutions, Inc. | 1 | $27 |
| Grifols USA, LLC | 1 | $18 |
Products named: NUCALA, FASENRA, TEZSPIRE, YUPELRI, TRELEGY ELLIPTA, BREZTRI, Monarch Platform, Xolair.
Industry payments across IN — which companies pay providers there.
